Skip to Main content Skip to Navigation
Journal articles

Multiple roles of macrophage migration inhibitory factor in pulmonary hypertension

Abstract : Pulmonary hypertension (PH) is a life-threatening condition arising from the loss and obstructive remodeling of the pulmonary arteries, leading to the sustained elevation of pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) and subsequently right ventricular (RV) failure and death. PH encompasses a group of multifactorial diseases, such as pulmonary arterial hypertension (PAH) and chronic thromboembolic PH, for which there is no treatment that can stop or reverse the progression of remodeling of the pulmonary vasculature. The identification of new molecular targets for the development of more effective drugs is thus urgently needed. In this context, macrophage migration inhibitory factor (MIF), a pleiotropic upstream proinflammatory mediator, is emerging as a promising molecular target, as it contributes to perivascular inflammation and pulmonary arterial remodeling, two key hallmarks of PAH that are not specifically targeted by currently approved therapies. The objective of this review is to summarize the scientific evidence on the pathogenic roles of MIF and its potential as a biomarker and therapeutic target in PH/PAH.
Complete list of metadata

Cited literature [67 references]  Display  Hide  Download
Contributor : Christophe Guignabert Connect in order to contact the contributor
Submitted on : Tuesday, May 19, 2020 - 12:19:10 PM
Last modification on : Friday, April 1, 2022 - 11:48:01 AM


Guignabert MS.pdf
Files produced by the author(s)



Gael Jalce, Christophe Guignabert. Multiple roles of macrophage migration inhibitory factor in pulmonary hypertension. American Journal of Physiology - Lung Cellular and Molecular Physiology, American Physiological Society, 2020, 318 (1), pp.L1-L9. ⟨10.1152/ajplung.00234.2019⟩. ⟨inserm-02454988⟩



Record views


Files downloads